We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Distribution Alliance for Adhesion Prevention

By HospiMedica staff writers
Posted on 23 Jul 2002
Print article
According to a new European distribution agreement, a bioabsorbable gel for the prevention of adhesions will be marketed in Europe by Depuy AcroMed, Inc. (Chagrin Falls, OH, USA).

Called Oxiplex/SP Gel, the product is applied during spinal surgery to reduce postoperative internal scarring, or adhesions. Adhesions are a leading complication of many surgical procedures. Oxiplex is a new polymer technology formulated for a variety of targeted medical indications and markets by FzioMed, Inc. (San Luis Obispo, CA, USA)(The gel will be distributed to orthopedic surgeons and neurosurgeons for use in spinal surgical procedures such as laminectomy and discectomy. FzioMed will manufacture the product and provide sales support and training assistance.
AcroMed is a leading worldwide supplier of spinal products.

"There is a great unmet need for an effective antiadhesion product in spine surgery,” said Ronald Haynes, president and CEO of FzioMed. "We look forward to working with our partner to bring Oxiplex/SP to surgeons in Europe.”




Related Links:
FzioMed
DePuy AcroMed
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Bioengineered Collagen Implant
Tapestry Biointegrative Implant
New
Fixed Volume Dispense Pump
LPL Series

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.